- Home
- AQST vs HBCP Comparison
AQST vs HBCP Comparison
Compare AQST & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | HBCP |
|---|---|---|
| Founded | 2004 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.0M | 453.4M |
| IPO Year | 2007 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AQST | HBCP |
|---|---|---|
| Price | $4.21 | $64.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $9.00 | ★ $63.50 |
| AVG Volume (30 Days) | ★ 1.4M | 142.5K |
| Earning Date | 05-11-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | N/A | ★ 29.01 |
| EPS | N/A | ★ 5.87 |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $10.08 | N/A |
| Revenue Next Year | $49.60 | $4.74 |
| P/E Ratio | ★ N/A | $11.01 |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.22 | $42.75 |
| 52 Week High | $7.55 | $65.95 |
Technical Indicators
Market Signals| Indicator | AQST | HBCP |
|---|---|---|
| Relative Strength Index (RSI) | 54.98 | 66.88 |
| Support Level | $3.70 | $56.27 |
| Resistance Level | $4.42 | N/A |
| Average True Range (ATR) | 0.15 | 1.88 |
| MACD | 0.01 | 0.46 |
| Stochastic Oscillator | 76.90 | 81.91 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.